EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Application of Artificial Intelligence in Tumor Immunotherapy: Integrating Multi-Omics Data to Achieve Efficacy Prediction and Combination Strategies

Gang Liu

Applied Artificial Intelligence Research · 24.06.2026 · 2 (2)

DOI: 10.65455/q72yq328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Artificial Intelligence Research, online erschienen am 24.06.2026. Verfasst von Gang Liu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet only a minority of patients achieve durable clinical benefit due to primary or acquired resistance. This heterogeneity necessitates precise predictive biomarkers and rational combination strategies. The rapid accumulation of multi-omics data-including genomics, transcriptomics, radiomics, pathomics, and microbiomics-offers unprecedented opportunities to decode tumor-immune interactions. Artificial intelligence, particularly machine learning and deep learning, excels at integrating high-dimensional, heterogeneous data to build interpretable efficacy prediction models and accelerate the discovery of synergistic combination regimens. In this review, we systematically summarize AI-based multimodal integration frameworks (e.g:deep multimodal fusion, graph neural networks, and single-cell omics models) and key technologies. We critically analyze the types and characteristics of multi-omics data used in immunotherapy prediction. Furthermore, we discuss AI-driven applications in personalized stratification, combination therapy target discovery, and drug synergy prediction. Finally, we identify current bottlenecks-including interpretability, data standardization, clinical validation, and model generalizability-and propose future directions. This review provides a systematic reference for transitioning from empirical treatment to data-driven precision immunotherapy.

Zitieren

APA

Liu, G. (2026). The Application of Artificial Intelligence in Tumor Immunotherapy: Integrating Multi-Omics Data to Achieve Efficacy Prediction and Combination Strategies. Applied Artificial Intelligence Research, 2(2). https://doi.org/10.65455/q72yq328

Vancouver

Liu G. The Application of Artificial Intelligence in Tumor Immunotherapy: Integrating Multi-Omics Data to Achieve Efficacy Prediction and Combination Strategies. Applied Artificial Intelligence Research. 2026;2(2). doi:10.65455/q72yq328

BibTeX
@article{Liu2026,
  author = {Liu, Gang},
  title = {The Application of Artificial Intelligence in Tumor Immunotherapy: Integrating Multi-Omics Data to Achieve Efficacy Prediction and Combination Strategies},
  journal = {Applied Artificial Intelligence Research},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.65455/q72yq328}
}
Kostenlos starten →